BTRX-246040

· BlackThorn Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BTRX-246040, covering 2021-05-11 to 2025-06-24. Get the full timeline:

Most recent: Clinical Trial Update: BTRX-246040 Study in Participants With Parkinson's Disease With Motor Fluctuations [Phase 2]